Sunday, April 13 | 3–4 p.m.
Helge Lubenow, Heidelberg Epignostix GmbH
Diagnostic AI models based on the methylation status of tumor samples classify cancer types precisely and objectively. We describe classification of central nervous system, soft tissue and bone tumors using a machine learning classifier algorithm based on array-generated DNA methylation data demonstrating the potential for optimized patient treatment in line with WHO guidelines.
The program includes sessions, networking opportunities, industry spotlights and more.
View program
